Skip to Content

Arundhati Parmar

Articles by this author:

MedCity News

St. Jude lead delivery device for chronic pain approved by FDA

By Arundhati Parmar | 07/13/11
St. Jude Medical Inc. announced Tuesday that it won U.S. Food & Drug Administration clearance for its Epiducer lead delivery system for neurostimulation in treatment of chronic pain.
MedCity News

FDA allows expansion of St. Jude study to treat severe depression

By Arundhati Parmar | 07/12/11
St. Jude announced that the Broaden severe-depression study that is testing its Libra investigational device will now be conducted at 20 medical centers with a total of 125 patients.
MedCity News

LifeScience Alley takes proactive step with new VP of government affairs

By Arundhati Parmar | 07/11/11
The Minnesota-based medical device industry lobbying group wants to be more proactive about how it addresses regulatory challenges for its membership.
MedCity News

Medtronic acquiring Salient Surgical, Peak Surgical for $620 million

By Arundhati Parmar | 07/08/11
The Minnesota maker of new innovative medical devices said that both the acquisitions will boost its surgical products portfolio.
MedCity News

Larry Renfro named CEO of Optum

By Arundhati Parmar | 07/07/11
Optum is Minnetonka-based UnitedHealth Group’s $27 billion health informatics unit made up of three business units — OptumInsight, OptumHealth and OptumRx.
MedCity News

Could Infuse furor force Medtronic to sell spine business?

By Arundhati Parmar | 07/06/11
A Wall Street analyst is speculating that Medtronic’s woes over its blockbuster Infuse product might lead the medical device company to pull the plug on the entire spinal business.
MedCity News

Health-care social network would move medical sales completely online

By Arundhati Parmar | 07/05/11
An emerging health IT startup in Minnesota wants to create a health-care social network that would move sales between vendors and hospital systems completely online.
MedCity News

Minnesota lawmakers critique FDA medical-devices policy over IDEs

By Arundhati Parmar | 07/01/11
The medical device industry’s favorite Congressional delegation has fired another salvo at the FDA approvals process.
MedCity News

New catheter-infection treatment company hopes to hit Europe by 2012

By Arundhati Parmar | 06/30/11
Two-year-old Pursuit Vascular, based in Blaine, is preparing to take the next step in marketing its device to prevent blood infection related to catheters.
MedCity News

Medtronic CEO moves to defuse Infuse controversy

By Arundhati Parmar | 06/29/11
Medtronic's Omar Ishrak isn’t wasting any time in responding to articles published in Spine Journal about the company’s controversial bone-graft product Infuse.Second Opinion: Medtronic's bone-graft studies receive harsh criticism from spine